AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 23 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $170,826,000 | +28.4% | 174,372,000 | +10.8% | 3.40% | +23.9% |
| Q2 2022 | $133,036,000 | -6.2% | 157,390,000 | 0.0% | 2.74% | -13.5% |
| Q1 2022 | $141,877,000 | +9.0% | 157,390,000 | 0.0% | 3.17% | +16.2% |
| Q4 2021 | $130,154,000 | -9.5% | 157,390,000 | 0.0% | 2.73% | -2.7% |
| Q3 2021 | $143,842,000 | -8.2% | 157,390,000 | 0.0% | 2.81% | +0.9% |
| Q2 2021 | $156,612,000 | +1.4% | 157,390,000 | +5.2% | 2.78% | -14.3% |
| Q1 2021 | $154,446,000 | +12.7% | 149,600,000 | 0.0% | 3.25% | +19.8% |
| Q4 2020 | $137,072,000 | +14.1% | 149,600,000 | 0.0% | 2.71% | -7.4% |
| Q3 2020 | $120,099,000 | – | 149,600,000 | – | 2.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 157,390,000 | $141,877,000 | 3.17% |
| Birch Grove Capital LP | 8,000,000 | $7,200,000 | 2.94% |
| PFM Health Sciences, LP | 48,150,000 | $43,919,000 | 1.64% |
| SILVERBACK ASSET MANAGEMENT LLC | 8,505,000 | $7,665,000 | 1.04% |
| DAFNA Capital Management LLC | 1,500,000 | $1,345,000 | 0.35% |
| DeepCurrents Investment Group LLC | 8,696,000 | $7,756,000 | 0.24% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,092,000 | $10,005,000 | 0.23% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,235,000 | $8,358,000 | 0.13% |
| Verition Fund Management LLC | 2,441,000 | $2,227,000 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $5,473,000 | 0.02% |